Calumet, Inc. (CLMT)
| Market Cap | 2.80B +212.4% |
| Revenue (ttm) | 4.17B -0.1% |
| Net Income | -188.80M |
| EPS | n/a |
| Shares Out | 87.15M |
| PE Ratio | n/a |
| Forward PE | 96.13 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,220,752 |
| Open | 32.53 |
| Previous Close | 34.61 |
| Day's Range | 31.15 - 34.16 |
| 52-Week Range | 11.38 - 36.94 |
| Beta | 0.72 |
| Analysts | Strong Buy |
| Price Target | 28.65 (-10.69%) |
| Earnings Date | May 8, 2026 |
About CLMT
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, a... [Read more]
Financial Performance
In 2025, Calumet's revenue was $4.14 billion, a decrease of -1.25% compared to the previous year's $4.19 billion. Losses were -$33.80 million, -84.77% less than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for CLMT stock is "Strong Buy." The 12-month stock price target is $28.65, which is a decrease of -10.69% from the latest price.
News
Calumet Earnings Call Transcript: Q1 2026
Q1 2026 saw strong market conditions and strategic progress, including the MaxSAF 150 expansion and robust specialty and renewables performance. Operational setbacks limited full margin capture, but price increases and hedging position the company for a strong Q2 and accelerated deleveraging.
Calumet reports Q1 basic EPS ($3.64) vs. ($1.87) last year
Reports Q1 revenue $1.03B vs. $993.9M last year. “The first quarter of 2026 marked a pivotal moment in Calumet’s (CLMT) transformation,” said Todd Borgmann, CEO. “Late in the quarter, we
Calumet Reports First Quarter 2026 Results
First Quarter 2026 net loss of $317.0 million, or basic loss per common share of $3.64, driven by non-cash RINs and other mark-to-market items First Quarter 2026 Adjusted EBITDA with Tax Attributes of...
Calumet downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs downgraded Calumet (CLMT) to Neutral from Buy with a price target of $36, up from $34. The firm cites valuation for the downgrade following the stock’s outperformance over
Calumet, Inc. to Release First Quarter 2026 Earnings on May 8, 2026
INDIANAPOLIS, April 23, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the First Quarter 2026 on...
Calumet Announces Intention to Nominate Bradford T. Sanders to Board of Directors
INDIANAPOLIS, April 6, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that Bradford T. Sanders has been selected as a nominee for election to the Board of Directors of C...
Calumet provides Q1 operational update
Calumet (CLMT) announced an operational update for Q1 2026. Shreveport Maintenance: late in Q1, its Shreveport facility required unplanned maintenance after discovering the presence of organic chlorid...
Calumet Announces First Quarter 2026 Operational Update
INDIANAPOLIS, April 2, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet" or the "Company") announced today an operational update for the first quarter of 2026. Shreveport Maintenance Late i...
Calumet price target raised to $60 from $33 at H.C. Wainwright
H.C. Wainwright analyst Amit Dayal raised the firm’s price target on Calumet (CLMT) to $60 from $33 and keeps a Buy rating on the shares. The firm cries expectations of
Calumet says Jennifer Straumins will no seek re-election to board
Calumet (CLMT) announced that Jennifer Straumins, a member of the company’s Board of Directors, has informed the Board of her decision not to seek re-election and to retire at the
Calumet Announces Board Member Will Not Stand for Re-Election
INDIANAPOLIS, March 25, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet" or the "Company") announced today that Jennifer Straumins, a member of the Company's Board of Directors (the "Board...
Calumet to Attend H.C. Wainwright Renewable Fuels Virtual Day
INDIANAPOLIS, March 18, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that it plans to attend the H.C. Wainwright Renewables Fuels Virtual Day on March 25th and will ho...
Calumet Completes Offering of $150 Million of Additional 9.75% Senior Notes due 2031
INDIANAPOLIS, March 17, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (th...
Calumet Announces Pricing of $150 Million Private Placement of Additional 9.75% Senior Notes due 2031
INDIANAPOLIS, March 12, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (th...
Calumet Announces $150 Million Private Placement of Additional 9.75% Senior Notes due 2031
INDIANAPOLIS, March 12, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that, subject to market conditions, its wholly owned subsidiaries, Calumet Specia...
Calumet price target raised to $34 from $24 at Goldman Sachs
Goldman Sachs analyst Neil Mehta raised the firm’s price target on Calumet (CLMT) to $34 from $24 and keeps a Buy rating on the shares. Estimates across U.S. Majors and
Calumet price target raised to $25 from $19 at TD Cowen
TD Cowen raised the firm’s price target on Calumet (CLMT) to $25 from $19 and keeps a Hold rating on the shares. The firm updated itsmodel after the company reiterated
TRUFUEL® Announces Record-Breaking Sales as Rapid Growth Continues
INDIANAPOLIS, March 4, 2026 /PRNewswire/ -- TRUFUEL®, an industry leader in precision-engineered fuel, has achieved the highest monthly sales volume in the company's history, eclipsing the brands' pre...
Calumet Earnings Call Transcript: Q4 2025
Delivered strong FY2025 results with $293M adjusted EBITDA, significant deleveraging, and record specialty production. Montana Renewables closed a transformative DOE loan and secured multi-year SAF contracts, positioning for further growth and margin expansion in 2026.
Calumet reports Q4 EPS (43c), consensus (46c)
Reports Q4 revenue $1.04B, consensus $1.06B. “2025 was a defining year for Calumet (CLMT),” said Todd Borgmann, CEO. “Throughout the year, we materially reduced financial risk, strengthened our balanc...
Calumet Reports Fourth Quarter and Fiscal Year 2025 Results
Fiscal Year 2025 net loss of $33.8 million, or basic loss per common share of $0.39 Fiscal Year 2025 Adjusted EBITDA with Tax Attributes of $293.3 million $222 million of recourse debt reduction in 20...
Calumet price target raised to $33 from $28 at BofA
BofA analyst Conor Fitzpatrick raised the firm’s price target on Calumet (CLMT) to $33 from $28 and keeps a Buy rating on the shares. The firm updated its model with
Montana Renewables and World Energy Join Forces to Drive Efficiency and Scale in Sustainable Aviation Fuel (SAF) Deliveries
Agreement signals ongoing growth of Sustainable Aviation Fuel market GREAT FALLS, Mont. and BOSTON, Feb. 19, 2026 /PRNewswire/ -- Montana Renewables, LLC (MRL) and World Energy Clean Fuels LLC (World ...
Calumet price target raised to $26 from $13.25 at UBS
UBS analyst Manav Gupta raised the firm’s price target on Calumet (CLMT) to $26 from $13.25 and keeps a Neutral rating on the shares.